With the exception of a run in the first quarter of 2014, the space between mid-2013 and mid-2014 was a dead zone for Intuitive Surgical (NASDAQ:ISRG)
shares as it became clear that growth at this traditionally high-growth
med-tech was slowing. System placements declined sequentially for five
of six quarters starting in the first quarter of 2013 and procedure
growth slowed as the medical community became less aggressive with
prostatectomy procedures and daVinci penetration topped out.
Sentiment
has been improving since mid-2014, though, helped by growing
penetration in general surgery and optimism that the new Xi and Sp
platforms and greater overseas sales efforts will reignite system
placements on an extended basis. Although Intuitive will likely start
seeing real competition relatively soon, this remains a pretty special
company within the med-tech space. The trouble is how much to pay for
those special qualities, as the Street is already back to expecting
quite a lot of growth from this company.
Read the full article here:
Intuitive Surgical Set To Regain Momentum In 2015
No comments:
Post a Comment